Over 1 in 10 American Adults Rely on Sleep Aids Nearly Every Night

Sleep is increasingly recognized as a foundational pillar of longevity and healthspan, yet a striking new report in JAMA suggests that a substantial portion of the American population may be relying on pharmacological or supplemental aids just to achieve it. The finding that more than 1 in 10 US adults use sleep aids most days has wide-reaching implications for clinicians, researchers, and health-conscious individuals alike.

The JAMA piece, published ahead of print in May 2026, reports on the prevalence of near-daily sleep aid use among US adults. While the specific methodology is not detailed in the abstract, the data likely draws on large-scale survey or surveillance sources, which are commonly used to track medication and supplement use patterns at the population level.

The central finding — that over 10% of American adults rely on sleep aids most days — is significant. This encompasses a broad category of interventions, potentially including prescription sedatives, antihistamines, melatonin, and other OTC preparations. The scale of use suggests that chronic sleep difficulty is not a fringe problem but a mainstream public health challenge.

For longevity practitioners and their patients, this matters because poor sleep is causally linked to accelerated cognitive decline, cardiovascular disease, metabolic dysfunction, and immune impairment. Chronic reliance on sleep aids, rather than addressing root causes, may perpetuate rather than solve these downstream risks.

Clinically, the data should prompt providers to screen more aggressively for insomnia disorder, sleep apnea, and circadian rhythm dysfunction. First-line treatments like cognitive behavioral therapy for insomnia (CBT-I) remain underutilized despite strong evidence. The findings also raise questions about supplement safety at scale, particularly long-term melatonin use across age groups. A population this reliant on external sleep support warrants urgent, systemic attention.